Clinical Prediction Model for Antibody-Mediated Rejection: A Strategy to Minimize Surveillance Endomyocardial Biopsies After Heart Transplantation.
Guillaume CoutanceEvan P KransdorfOlivier AubertGuillaume BonnetDaniel YooPhilippe RouvierJean-Paul Duong Van HuyenPatrick BrunevalJean-Luc TaupinPascal LeprinceShaida VarnousJon KobashigawaXavier JouvenJignesh K PatelAlexandre LoupyPublished in: Circulation. Heart failure (2022)
Our results support the use of the AMR risk model as a clinical decision tool to minimize the number of routine EMB after heart transplantation.